Literature DB >> 17666490

Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle.

Vitor A Lira1, Quinlyn A Soltow, Jodi H D Long, Jenna L Betters, Jeff E Sellman, David S Criswell.   

Abstract

Nitric oxide (NO) and 5'-AMP-activated protein kinase (AMPK) are involved in glucose transport and mitochondrial biogenesis in skeletal muscle. Here, we examined whether NO regulates the expression of the major glucose transporter in muscle (GLUT4) and whether it influences AMPK-induced upregulation of GLUT4. At low levels, the NO donor S-nitroso-N-penicillamine (SNAP, 1 and 10 microM) significantly increased GLUT4 mRNA ( approximately 3-fold; P < 0.05) in L6 myotubes, and cotreatment with the AMPK inhibitor compound C ablated this effect. The cGMP analog 8-bromo-cGMP (8-Br-cGMP, 2 mM) increased GLUT4 mRNA by approximately 50% (P < 0.05). GLUT4 protein expression was elevated 40% by 2 days treatment with 8-Br-cGMP, whereas 6 days treatment with 10 microM SNAP increased GLUT4 expression by 65%. Cotreatment of cultures with the guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one prevented the SNAP-induced increase in GLUT4 protein. SNAP (10 microM) also induced significant phosphorylation of alpha-AMPK and acetyl-CoA carboxylase and translocation of phosphorylated alpha-AMPK to the nucleus. Furthermore, L6 myotubes exposed to 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside (AICAR) for 16 h presented an approximately ninefold increase in GLUT4 mRNA, whereas cotreatment with the non-isoform-specific NOS inhibitor N(G)-nitro-l-arginine methyl ester, prevented approximately 70% of this effect. In vivo, GLUT4 mRNA was increased 1.8-fold in the rat plantaris muscle 12 h after AICAR injection, and this induction was reduced by approximately 50% in animals cotreated with the neuronal and inducible nitric oxide synthases selective inhibitor 1-(2-trifluoromethyl-phenyl)-imidazole. We conclude that, in skeletal muscle, NO increases GLUT4 expression via a cGMP- and AMPK-dependent mechanism. The data are consistent with a role for NO in the regulation of AMPK, possibly via control of cellular activity of AMPK kinases and/or AMPK phosphatases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17666490     DOI: 10.1152/ajpendo.00045.2007

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  52 in total

1.  Nitric oxide and AMPK cooperatively regulate PGC-1 in skeletal muscle cells.

Authors:  Vitor A Lira; Dana L Brown; Ana K Lira; Andreas N Kavazis; Quinlyn A Soltow; Elizabeth H Zeanah; David S Criswell
Journal:  J Physiol       Date:  2010-07-19       Impact factor: 5.182

Review 2.  Multi-regulatory network of ROS: the interconnection of ROS, PGC-1 alpha, and AMPK-SIRT1 during exercise.

Authors:  Anand Thirupathi; Claudio Teodoro de Souza
Journal:  J Physiol Biochem       Date:  2017-07-14       Impact factor: 4.158

Review 3.  In vitro experimental models for examining the skeletal muscle cell biology of exercise: the possibilities, challenges and future developments.

Authors:  Steven Carter; Thomas P J Solomon
Journal:  Pflugers Arch       Date:  2018-10-05       Impact factor: 3.657

4.  Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the transgenic (mRen2) rat.

Authors:  Lixin Ma; Rukhsana Gul; Javad Habibi; Ming Yang; Lakshmi Pulakat; Adam Whaley-Connell; Carlos M Ferrario; James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-23       Impact factor: 4.733

5.  Nitric oxide modulates bone anabolism through regulation of osteoblast glycolysis and differentiation.

Authors:  Zixue Jin; Jordan Kho; Brian Dawson; Ming-Ming Jiang; Yuqing Chen; Saima Ali; Lindsay C Burrage; Monica Grover; Donna J Palmer; Dustin L Turner; Philip Ng; Sandesh Cs Nagamani; Brendan Lee
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

Review 6.  AMP-activated protein kinase and metabolic control.

Authors:  Benoit Viollet; Fabrizio Andreelli
Journal:  Handb Exp Pharmacol       Date:  2011

7.  Suppression of the GLUT4 adaptive response to exercise in fructose-fed rats.

Authors:  Veeraj Goyaram; Tertius A Kohn; Edward O Ojuka
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-10       Impact factor: 4.310

Review 8.  Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity.

Authors:  Joseph Fomusi Ndisang
Journal:  Mediators Inflamm       Date:  2010-05-18       Impact factor: 4.711

9.  Nitric oxide increases cyclic GMP levels, AMP-activated protein kinase (AMPK)alpha1-specific activity and glucose transport in human skeletal muscle.

Authors:  A S Deshmukh; Y C Long; T de Castro Barbosa; H K R Karlsson; S Glund; W J Zavadoski; E M Gibbs; H A Koistinen; H Wallberg-Henriksson; J R Zierath
Journal:  Diabetologia       Date:  2010-03-27       Impact factor: 10.122

10.  A soluble guanylate cyclase-dependent mechanism is involved in the regulation of net hepatic glucose uptake by nitric oxide in vivo.

Authors:  Zhibo An; Jason J Winnick; Ben Farmer; Doss Neal; Margaret Lautz; Jose M Irimia; Peter J Roach; Alan D Cherrington
Journal:  Diabetes       Date:  2010-09-07       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.